Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | TPMT | P51580 | 1/20 | 0.44 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.42 |
| ▸ | HTR3B | O95264 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15164796 | 0.87 | CA2 (0.46) | CA2CA12CA1CA7CA9 | |
| SCHEMBL30881089 | 0.85 | CA2 (0.45) | CA2CA12CA1CA7CA9 | |
| SCHEMBL12062507 | 0.85 | CYP19A1 (0.54) | ACHECYP3A4ALDH1A1 | |
| SCHEMBL29209166 | 0.85 | CA2 (0.45) | CA2CA12CA1CA7CA9 | |
| Ammonia Solution, Strong SCHEMBL8004534 | 0.84 | PDE4A (0.48) | TSHRL3MBTL1PDE4APDE4BPDE4C | |
| SCHEMBL9274477 | 0.83 | LMNA (0.41) | CA2CA1L3MBTL1CYP3A4HTT | |
| SCHEMBL14934286 | 0.83 | CYP19A1 (0.45) | CYP2C9 | |
| SCHEMBL11395533 | 0.83 | CASP1 (0.46) | CA2CA12CA1CA7CA9 | |
| SCHEMBL29732589 | 0.83 | LMNA (0.41) | CA2CA1L3MBTL1CYP3A4HTT | |
| SCHEMBL17294217 | 0.83 | MAOB (0.55) | CA2TSHRKMT2AHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6608232-B1 | Acylating an aromatic compound in presence of zeolite or friedel crafts catalyst, reduction to a carbinol and cata-lytic etherification | Chimie, Rhodia (FR) | 2003-08-19 | — | — | US | claimed |
| EP-0994838-B1 | METHOD FOR ETHERIFYING A BENZYL ALCOHOL, RESULTING PRODUCTS AND APPLICATIONS | RHODIA CHIMIE SA (FR) | 2003-05-21 | — | — | EP | claimed |
| US-6362378-B1 | REACTION WITH AN ALCOHOL; ZEOLITE CATALYST; PERFUMES | RHODIA CHIMIE (FR) | 2002-03-26 | — | — | US | claimed |
| EP-1140758-A1 | METHOD FOR PREPARING A BENZYLIC-TYPE ETHER | RHODIA CHIMIE (FR) | 2001-10-10 | — | — | EP | claimed |
| CN-1267277-A | Method for etherifying benzyl alcohol, resulting products and applications | RHODIA CHIMIE SA (FR) | 2000-09-20 | — | — | CN | claimed |
| WO-2000040535-A1 | METHOD FOR PREPARING A BENZYLIC-TYPE ETHER | RHODIA CHIMIE (FR) | 2000-07-13 | — | — | WO | claimed |
| EP-0994838-A1 | METHOD FOR ETHERIFYING A BENZYL ALCOHOL, RESULTING PRODUCTS AND APPLICATIONS | RHODIA CHIMIE (FR) | 2000-04-26 | — | — | EP | claimed |
| WO-1999002475-A1 | METHOD FOR ETHERIFYING A BENZYL ALCOHOL, RESULTING PRODUCTS AND APPLICATIONS | RHODIA CHIMIE (FR) | 1999-01-21 | — | — | WO | claimed |
| US-20080269202-A1 | Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-10-30 | — | — | US | disclosed |
| WO-2008124075-A1 | NOVEL 2,3-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS ANTIPSYCHOTIC AGENTS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-10-16 | — | — | WO | disclosed |
| US-6608232-B1 | Acylating an aromatic compound in presence of zeolite or friedel crafts catalyst, reduction to a carbinol and cata-lytic etherification | Chimie, Rhodia (FR) | 2003-08-19 | — | — | US | disclosed |
| EP-0994838-B1 | METHOD FOR ETHERIFYING A BENZYL ALCOHOL, RESULTING PRODUCTS AND APPLICATIONS | RHODIA CHIMIE SA (FR) | 2003-05-21 | — | — | EP | disclosed |
| US-6362378-B1 | REACTION WITH AN ALCOHOL; ZEOLITE CATALYST; PERFUMES | RHODIA CHIMIE (FR) | 2002-03-26 | — | — | US | disclosed |
| US-6320085-B1 | REACTING BENZYL ALCOHOL DERIVATIVE WITH 1 TO 3 MOLAR EQUIVALENTS OF SPECIFIED ALCOHOL IN PRESENCE OF ACID, LEWIS ACID, METAL OXIDE OR METAL CARBONATE, ISOLATING RESULTING ETHER, STABILIZING BY ADDITION OF BASE AND/OR ANTIOXIDANT | AGRO-CHEMIE NOVENYVEDOSZER GYARTO ERTEKESITO EST FORGALMAZO KFT. (HU) | 2001-11-20 | — | — | US | disclosed |
| EP-0550111-A1 | 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them | STERLING WINTHROP INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| EP-0550112-A1 | 2-Saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and pharmaceutical compositions contaning them | STERLING WINTHROP INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| EP-0549073-A1 | Novel 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof | STERLING WINTHROP INC. (US) | 1993-06-30 | — | — | EP | disclosed |
| US-5187173-A | Degenerative diseases such as emphysema, rheumatoid arthritis, pancreatitis, cyctic fibrosis and skin disorders | STERLING WINTHROP INC. (US) | 1993-02-16 | — | — | US | disclosed |
| US-5128339-A | Emphysema, rheumatoid arthritis, pancreatitis | STERLING WINTHROP INC. (US) | 1992-07-07 | — | — | US | disclosed |
| EP-0483928-A1 | 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use | STERLING WINTHROP INC. (US) | 1992-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269202-A1 | Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents | GABRA3, GABRB3, GABRA4 | CA2 3684/4885CA12 3871/4885CA1 2848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.